CRBP CORBUS PHARMACEUTICA

6.75
+0.20  (3%)
Previous Close 6.55
Open 6.65
Price To book 7.54
Market Cap 338.97M
Shares 50,218,000
Volume 361,815
Short Ratio 4.72
Av. Daily Volume 1,162,240

SEC filingsSee all SEC filings

  1. 8-K - Current report 17826397
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 17824849
  3. 8-K - Current report 17824827
  4. 8-K - Current report 17768869
  5. DEF 14A - Other definitive proxy statements 17753970

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 data released March 30, 2017 - primary endpoint met but some concerns regarding efficacy.
Anabasum (Resunab)
Cystic Fibrosis
Phase 2 trial to be initiated 2H 2017.
Anabasum (Resunab)
Systemic lupus erythematosus (SLE)
Phase 2 data due 4Q 2017.
Anabasum (Resunab)
Dermatomyositis
Phase 2 data released November 14, 2016. Phase 3 trial to be initiated 4Q 2017 with data due end of 2019.
Anabasum (Resunab)
Systemic Sclerosis

Latest News

  1. ETFs with exposure to Corbus Pharmaceuticals Holdings, Inc. : May 22, 2017
  2. Better Know a Marijuana Stock: Corbus Pharmaceuticals
  3. Top 4 Marijuana Stocks to Watch for 2017
  4. Corbus Pharmaceuticals Announces Last Subject Enrolled in Phase 2 Study of Anabasum for the Treatment of Skin-Predominant Dermatomyositis
  5. Corbus Pharmaceuticals Holdings, Inc. :CRBP-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017
  6. Today's Research Reports on Corbus Pharmaceuticals and Pluristem Therapeutics Post Earnings
  7. Corbus Pharmaceuticals reports 1Q loss
  8. Corbus Pharmaceuticals Reports 2017 First Quarter Financial Results and Provides Business Update
  9. The 3 Most Undervalued Marijuana Stocks (With a Twist)
  10. Lifshitz & Miller LLP Announces Investigation of Bingo Nation Inc., BofI Holding, Inc., Corbus Pharmaceuticals Holdings, Inc., Lion Biotechnologies, Inc., NewLink Genetics Corporation, Power Solutions International, Inc., Walter Investment Management Corp. and XBIOTECH INC.
  11. Which Marijuana Stock Will Be Next to Reach a $1 Billion Valuation?
  12. Read This Before You Buy Biotech Stocks
  13. Top 4 Medicinal Marijuana Stocks to Watch for 2017
  14. Yikes! These 5 Marijuana Stocks Lost a Combined $193 Million in 2016
  15. Big Investors Backing A Marijuana Boom In 2017
  16. Did Corbus Investors Get Thrown Off by a Red Herring?
  17. 5 Drug-Developing Marijuana Stocks You Need to Know
  18. What's Next for Corbus Pharmaceuticals After Its Controversial Cystic Fibrosis Results?
  19. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Corbus Pharmaceuticals Holdings, Inc.

SEC Filings

  1. 8-K - Current report 17826397
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 17824849
  3. 8-K - Current report 17824827
  4. 8-K - Current report 17768869
  5. DEF 14A - Other definitive proxy statements 17753970
  6. PRE 14A - Other preliminary proxy statements 17730638
  7. 8-K - Current report 17723759
  8. 8-K - Current report 17685906
  9. 8-K - Current report 17676852
  10. S-8 - Securities to be offered to employees in employee benefit plans 17676288